Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Cirrhotic cardiomyopathy: pathogenesis and clinical relevance

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Too many people with viral hepatitis are diagnosed late - with dire consequences

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  2. Many European countries 'flying blind' in their efforts to eliminate viral hepatitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. NAFLD: Cardiovascular complications of NAFLD-they do matter

    Publikation: Bidrag til tidsskriftLetterpeer review

  4. IBD medications during pregnancy and lactation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Viral hepatitis: Cell-culture-derived HCV--a promising vaccine antigen

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Hepatic steatosis associated with exposure to elvitegravir and raltegravir

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Pheochromocytoma induced cardiomyopathy in a young man: a case report

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Pathophysiology Behind Cardiopulmonary Complications of Cirrhosis and Portal Hypertension

    Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologiFormidling

Vis graf over relationer
Cirrhosis is known to cause alterations in the systemic haemodynamic system. Cirrhotic cardiomyopathy designates a cardiac dysfunction that includes impaired cardiac contractility with systolic and diastolic dysfunction, as well as electromechanical abnormalities in the absence of other known causes of cardiac disease. This condition is primarily revealed by inducing physical or pharmacological stress, but echocardiography is excellent at revealing diastolic dysfunction and might also be used to detect systolic dysfunction at rest. Furthermore, measurement of circulating levels of cardiac biomarkers could improve the diagnostic assessm+ent. Cirrhotic cardiomyopathy contributes to various complications in cirrhosis, especially as an important factor in the development of hepatic nephropathy. Additionally, cirrhotic cardiomyopathy seems to be associated with the development of heart failure in relation to invasive procedures such as shunt insertion and liver transplantation. Current pharmacological treatment is nonspecific and directed towards left ventricular failure, and liver transplantation is currently the only proven treatment with specific effect on cirrhotic cardiomyopathy.
OriginalsprogEngelsk
TidsskriftNature reviews. Gastroenterology & hepatology
Vol/bind11
Sider (fra-til)177-186
Antal sider10
ISSN1759-5045
DOI
StatusUdgivet - mar. 2014

ID: 41120027